Form 8-K - Current report:
SEC Accession No. 0000318306-14-000035
Filing Date
2014-10-23
Accepted
2014-10-23 16:41:19
Documents
5
Period of Report
2014-10-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K r8k-532.htm 8-K 41825
2 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION ex_3-14.htm EX-3.14 10730
3 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF DESIGNATIONS, RIGHTS AND PREFERENCES ex_3-15.htm EX-3.15 23238
4 SHARE EXCHANGE AGREEMENT FOR SERIES B PREFERRED STOCK ex_10-33.htm EX-10.33 44611
5 UNSECURED GRID NOTE $250,000 ex_20-1.htm EX-20.1 138924
  Complete submission text file 0000318306-14-000035.txt   260883
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 141170383
SIC: 2834 Pharmaceutical Preparations